REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.35
-0.40 (-5.93%)
At close: May 22, 2026, 4:00 PM EDT
6.42
+0.07 (1.10%)
After-hours: May 22, 2026, 7:28 PM EDT

REGENXBIO Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-290.01-193.88-227.1-263.49-280.32127.84
Depreciation & Amortization
15.5215.6216.2217.3212.919.56
Stock-Based Compensation
34.6434.5638.4640.2740.7938.81
Other Adjustments
12.277.96-6.23-1.615.162.45
Change in Receivables
9.02-7.669.713.944.8214.12
Changes in Accounts Payable
1.72-2.28-0.29-2.7918.79-2.3
Changes in Accrued Expenses
-2.020.23-12.122.45-25.6229.91
Changes in Unearned Revenue
-11.1929.28-0.03-1.51-1.17-0.9
Changes in Other Operating Activities
-3.66-7.788.28-12.9717.15-0.61
Operating Cash Flow
-233.78-123.96-173.13-218.41-207.49218.88
Capital Expenditures
-2.63-2.41-2.44-9.96-30.72-84.18
Purchases of Investments
-323.31-332.63-190.14-86.56-184.88-498.14
Proceeds from Sale of Investments
335.85319.18296.02287.47203.67175.68
Investing Cash Flow
9.98-15.87103.45190.94-11.93-406.64
Long-Term Debt Issued
72.23144.49----0.27
Long-Term Debt Repaid
-35.88-28.1-39.85-42.3-33.1-26.59
Net Long-Term Debt Issued (Repaid)
36.35116.4-39.85-42.3-33.1-26.86
Issuance of Common Stock
1.261.01133.457.754.55222.11
Repurchase of Common Stock
-0.95-0.63-0.91-0.42-0.28-0
Net Common Stock Issued (Repurchased)
0.310.38132.547.334.26222.11
Financing Cash Flow
108.93116.7792.68-34.97-28.84195.25
Net Cash Flow
-114.88-23.0623-62.43-248.267.48
Free Cash Flow
-236.4-126.38-175.56-228.37-238.21134.7
FCF Margin
-269.18%-74.15%-210.69%-253.06%-211.32%28.64%
Free Cash Flow Per Share
-4.56-2.45-3.55-5.22-5.523.07
Levered Free Cash Flow
-255.92-44.84-257.35-313.25-322.0852.47
Unlevered Free Cash Flow
-258.95-128.56-223.74-275.44-271.4696.28
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q